{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:49:45Z","timestamp":1761468585975,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD016226","R01AI120670"],"award-info":[{"award-number":["S10OD016226","R01AI120670"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.tube.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T21:56:39Z","timestamp":1559771799000},"page":"52-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies"],"prefix":"10.1016","volume":"117","author":[{"given":"Amanda","family":"Walz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep B.","family":"Lukka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camron","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Creissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Meibohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Gonzalez-Juarrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5906","key":"10.1016\/j.tube.2019.06.002_bib1","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1164571","article-title":"PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.tube.2019.06.002_bib2","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"journal-title":"WHO. Global tuberculosis report.","first-page":"40","year":"2018","key":"10.1016\/j.tube.2019.06.002_bib3"},{"issue":"3","key":"10.1016\/j.tube.2019.06.002_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S2213-2600(15)00063-6","article-title":"Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies","volume":"3","author":"Zumla","year":"2015","journal-title":"Lancet Respir. Med."},{"year":"2006","series-title":"Biosafety recommendations for the contained use of Mycobacterium tuberculosis complex isolates in industrialized countries","author":"Herman","key":"10.1016\/j.tube.2019.06.002_bib5"},{"issue":"8","key":"10.1016\/j.tube.2019.06.002_bib6","first-page":"545","article-title":"A steric block in translation caused by the antibiotic spectinomycin","volume":"2","author":"Borovinskaya","year":"2007","journal-title":"ASC Chem. Biol."},{"issue":"2","key":"10.1016\/j.tube.2019.06.002_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nm.3458","article-title":"A new class of semisynthetic anti-tuberculosis agents that overcome native drug efflux","volume":"20","author":"Lee","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.tube.2019.06.002_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/acsinfecdis.6b00158","article-title":"Structure-activity relationships of spectinamide antituberculosis agents: a dissection of ribosomal inhibition and native efflux avoidance contributions","volume":"3","author":"Liu","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.tube.2019.06.002_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2018.11.006","article-title":"Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis","volume":"127","author":"Vaddady","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.tube.2019.06.002_bib10","doi-asserted-by":"crossref","unstructured":"Rathi, C., Lukka, P.B., Wagh, S., Lee, R.E., Lenaerts, A.J., Braunstein, M., Hickey, A., Gonzalez-Juarrero, M., and B. Meibohm. Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice. Tuberculosis, 114, 119-122. https:\/\/doi.org\/10.1016\/j.tube.2018.12.006.","DOI":"10.1016\/j.tube.2018.12.006"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297921930085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297921930085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:42:49Z","timestamp":1761468169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147297921930085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":10,"alternative-id":["S147297921930085X"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2019.06.002","relation":{},"ISSN":["1472-9792"],"issn-type":[{"type":"print","value":"1472-9792"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}